查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840599

植入式心臟整流去顫器市場（按產品類型、適應症、技術和最終用戶）—2025-2032 年全球預測

Implantable Cardioverter Defibrillators Market by Product Type, Indication, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

植入式心臟整流去顫器市場預計到 2032 年將成長至 76.6 億美元，複合年成長率為 6.19%。

主要市場統計數據
基準年2024年 47.3億美元
預計2025年 50.3億美元
預測年份：2032年 76.6億美元
複合年成長率（%） 6.19%

簡要概述設備創新、不斷發展的臨床實踐以及衛生系統壓力如何再形成ICD 治療的作用和提供方式。

植入式心臟整流去顫器(ICD) 是現代心臟護理的基石，為面臨心臟猝死風險的患者提供挽救生命的治療。過去十年，隨著材料科學、電池技術、感測演算法和遠端連接的進步，設備設計、植入技術和輔助監測技術取得了顯著發展。這些創新重塑了患者選擇、追蹤模式和臨床結果，同時也在電生理學、設備工程和數位健康領域創造了新的介面。

隨著臨床實踐日益複雜，醫院、診所和門診手術中心的相關人員必須將不斷發展的證據與實際操作相結合。第一級預防指徵和二級預防指徵之間的相互作用變得更加微妙，如今複雜的風險分層可以告知哪些人將從植入中受益最多。同時，MRI 相容性和遠端監控等技術變革擴展了設備的效用，同時也引入了有關設備壽命、互通性和資料管治的新考量。因此，決策者必須在應對監管和報銷動態的同時，平衡臨床有效性、病人安全性和經濟永續性。

技術進步、臨床通訊協定的演變以及醫療保健服務的轉變從根本上重新定義了 ICD 護理和醫療保健提供者的優先事項。

在技​​術、臨床和系統層面力量融合的推動下，ICD治療正在經歷變革時期。微型化和皮下植入式設計降低了操作複雜性和設備相關感染，而導線技術和感測演算法的進步則提高了心律不整的識別率，並減少了不恰當的治療。除了硬體創新之外，軟體增強和基於雲端的遠端監控也支援縱向資料收集，促進主動設備管理，並透過與遠端醫療的整合來增強患者參與度。

法律規範和臨床路徑正在適應這些進步，這不僅加速了具有增強遠端控制功能的MRI相容系統和設備的普及，也提高了真實世界證據和長期安全數據的標準。門診手術中心的選擇性ICD植入手術數量正在增加，而醫院和專科心臟中心處理的病例也越來越複雜。總的來說，這些轉變正在改變採購優先事項、臨床工作流程和價值評估，需要製定整合策略，使產品設計與現代心臟護理的營運現實一致。

檢驗近期關稅政策和貿易動態如何重塑整個 ICD 價值鏈的供應策略、成本壓力和臨床准入考慮

關稅和貿易政策變化對ICD生態系統的累積影響，正在為製造商、經銷商和醫療保健系統帶來新的複雜性。關稅波動會影響上游零件的成本，包括半導體晶片、電池材料和電子次組件，進而影響籌資策略和供應商多元化。為此，製造商正在審查其採購足跡並重新評估供應契約，以減輕貿易驅動的成本波動的影響。

下游醫院和門診手術中心面臨著在保持預算靈活性的同時，持續獲取最新設備技術的壓力。成本控制與臨床需求之間的矛盾促使他們對總體擁有成本、備件庫存和前置作業時間進行嚴格審查。在某些情況下，製造商正在加快區域製造和本地組裝計劃，以減輕關稅的影響並提高準時交付能力。伴隨此策略轉變的是商業團隊和臨床相關人員之間更緊密的合作，以根據臨床緊急程度和預期結果確定醫療設備的優先分配。最終，貿易政策的變化並非千篇一律，其累積影響受到設備製造商和醫療系統實施的合約結構、監管要求和供應鏈策略的靈活性的影響。

深度細分洞察，將產品架構、臨床適應症、實行技術和醫療保健環境與採用促進因素和策略機會聯繫起來

細分分析揭示了不同產品類型、治療適應症、賦能技術和護理環境的差異化效用促進因素和臨床實用性。產品類型包括皮下、經靜脈和穿戴式ICD，每種類型都滿足不同的臨床需求。皮下系統優先考慮避免感染和減少血管內硬體，經靜脈設備提供起搏治療和更深入的節律管理功能，穿戴式解決方案則可在高風險時期提供臨時保護或支持。基於適應症的患者路徑由一級和二級預防範式構建，植入適應症和時機由強調風險分層、合併症概況和預期壽命考慮的決策演算法確定。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 將無線遠端監控和數據分析整合到 ICD植入中，實現主動患者管理
  • 開發無線皮下 ICD 系統，降低感染風險並提高病患舒適度
  • 在植入裝置中實施人工智慧驅動的心律不整檢測演算法，以提高治療準確性
  • MRI 相容去心房顫動可為植入患者提供更廣泛的影像
  • 在 ICD 中使用小型電池技術來延長設備壽命並減少更換手術
  • 設備製造商和數位健康平台合作實現無縫患者依從性追蹤

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章植入式心臟整流去顫器市場（依產品類型）

  • 皮下植入式心臟復律去顫器
  • 經靜脈ICD
  • 穿戴式ICD

第9章植入式心臟整流去顫器市場（按適應症）

  • 第一級預防
  • 二級預防

第 10 章：植入式心臟整流去顫器市場（依技術）

  • MRI相容
  • 啟用遠端監控

第 11 章植入式心臟整流去顫器市場（依最終用戶）

  • 門診手術中心
  • 心臟護理中心
  • 診所
  • 醫院

第 12 章植入式心臟整流去顫器市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章植入式心臟整流去顫器市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章植入式心臟整流去顫器市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • BIOTRONIK SE & Co. KG
    • MicroPort Scientific Corporation
    • LivaNova PLC
    • Lepu Medical Technology Co., Ltd.
    • Stryker Corporation
    • ZOLL Medical Corporation
    • Kestra Medical Technologies Inc.
Product Code: MRR-037F3DB25943

The Implantable Cardioverter Defibrillators Market is projected to grow by USD 7.66 billion at a CAGR of 6.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.73 billion
Estimated Year [2025] USD 5.03 billion
Forecast Year [2032] USD 7.66 billion
CAGR (%) 6.19%

A concise framing of how device innovation, evolving clinical practice, and health system pressures are reshaping the role and delivery of ICD therapy

Implantable cardioverter defibrillators (ICDs) are a cornerstone of modern cardiac care, providing life-saving therapy to patients at risk of sudden cardiac death. Over the past decade, device design, implantation techniques, and adjunctive monitoring have evolved significantly, driven by advances in materials science, battery technology, sensing algorithms, and remote connectivity. These innovations have reshaped patient selection, follow-up paradigms, and clinical outcomes, while creating new intersections between electrophysiology, device engineering, and digital health.

As the clinical landscape becomes more complex, stakeholders across hospitals, clinics, and ambulatory surgical centers must reconcile evolving evidence with operational realities. The interplay between primary and secondary prevention indications has become more nuanced, with refined risk stratification informing who benefits most from implantation. Concurrently, technology shifts such as MRI compatibility and remote monitoring have expanded device utility, but also introduced new considerations for device longevity, interoperability, and data governance. The resulting environment requires decision-makers to balance clinical efficacy, patient safety, and economic sustainability while navigating regulatory and reimbursement dynamics.

How converging technological breakthroughs, evolving clinical protocols, and care delivery shifts are fundamentally redefining ICD therapy and provider priorities

ICD therapy is undergoing a period of transformative change driven by converging technological, clinical, and system-level forces. Miniaturization and subcutaneous designs are reducing procedural complexity and device-related infections, while advances in lead technology and sensing algorithms improve arrhythmia discrimination and reduce inappropriate therapy. Parallel to hardware innovation, software enhancements and cloud-enabled remote monitoring are enabling longitudinal data capture, facilitating proactive device management, and enhancing patient engagement through telehealth integrations.

Regulatory frameworks and clinical pathways are adapting to these advances, accelerating pathways for MRI-compatible systems and devices with enhanced remote capabilities, but also raising the bar for real-world evidence and long-term safety data. Health systems are responding by evolving care models; ambulatory surgical centers are increasingly performing elective ICD implants, while hospitals and specialized cardiac centers retain complex cases. Collectively, these shifts are changing procurement priorities, clinical workflows, and value assessments, demanding integrated strategies that align product design with the operational realities of contemporary cardiac care.

Examining how recent tariff policies and trade dynamics have reshaped supply strategies, cost pressures, and clinical access considerations across the ICD value chain

The cumulative impact of tariff actions and trade policy changes on the ICD ecosystem has introduced new layers of complexity for manufacturers, distributors, and health systems. Tariff fluctuations affect upstream component costs, including semiconductor chips, battery materials, and electronic subassemblies, thereby influencing procurement strategies and supplier diversification. In response, manufacturers are reassessing sourcing footprints and reevaluating supply contracts to mitigate exposure to trade-driven cost variability.

Downstream, hospitals and ambulatory surgical centers face pressure to preserve budgetary flexibility while maintaining access to the latest device technologies. The tension between cost containment and clinical necessity has prompted greater scrutiny of total cost of ownership, spare parts inventories, and lead times. In some cases, manufacturers are accelerating plans for regional manufacturing or localized assembly to reduce tariff impact and strengthen just-in-time delivery capabilities. These strategic shifts are accompanied by closer collaboration between commercial teams and clinical stakeholders to prioritize device allocations based on clinical urgency and outcome expectations. Ultimately, trade policy changes are not uniform in effect; their cumulative impact is mediated by contract structures, regulatory requirements, and the agility of supply chain strategies implemented by device makers and health systems alike.

Deep segmentation insights that connect product architecture, clinical indication, enabling technologies, and care settings to adoption drivers and strategic opportunities

Segmentation analysis reveals differentiated drivers of adoption and clinical utility across product types, therapeutic indications, enabling technologies, and care settings. Based on Product Type, the landscape includes Subcutaneous ICDs, Transvenous ICDs, and Wearable ICDs, each addressing distinct clinical needs: subcutaneous systems prioritize infection avoidance and reduced intravascular hardware, transvenous devices offer pacing therapies and deeper rhythm management capabilities, while wearable solutions serve as interim protection or as adjuncts for high-risk periods. Based on Indication, patient pathways are framed by Primary Prevention and Secondary Prevention paradigms, with decision algorithms emphasizing risk stratification, comorbidity profiles, and life expectancy considerations that inform candidacy and timing for implantation.

Based on Technology, MRI Compatible and Remote Monitoring Enabled devices redefine post-implant care and diagnostic confidence, as MRI compatibility reduces barriers to advanced imaging and remote monitoring supports proactive device management and early detection of complications. Based on End User, Ambulatory Surgical Centers, Cardiac Care Centers, Clinics, and Hospitals embody different procedural volumes, case complexity, and infrastructure capacities, which in turn influence purchasing criteria, service agreements, and clinical support needs. Understanding these intersecting segment dynamics is essential for targeting innovation efforts, designing differentiated commercial propositions, and aligning clinical training and support services with the environments where devices are implanted and managed.

Regional dynamics and differentiated adoption pathways that illuminate how reimbursement, regulatory maturity, and care delivery models shape ICD access and deployment

Regional dynamics underscore heterogeneous adoption patterns, reimbursement environments, and regulatory frameworks that shape ICD strategy by geography. In the Americas, established reimbursement pathways and high procedural volumes coexist with growing emphasis on cost containment and value-based procurement, prompting device providers to demonstrate comparative effectiveness and long-term performance. The Europe, Middle East & Africa region presents a mosaic of regulatory maturity and healthcare funding models, where some markets rapidly adopt advanced features such as MRI compatibility while others prioritize basic access and affordability, thus requiring differentiated market entry and pricing approaches.

In the Asia-Pacific region, rapid investment in cardiac infrastructure and increasing uptake of minimally invasive techniques are expanding indications for device therapy, but market heterogeneity remains pronounced across public and private systems. Across all regions, regional clinical networks, investigator-led registries, and local guidelines influence adoption curves and post-market evidence requirements. Manufacturers and health systems that tailor value propositions to regional nuances-balancing clinical performance, service models, and pricing-can better navigate reimbursement complexities and accelerate responsible access to device therapy.

Key competitive and strategic company trends highlighting where product innovation, partnerships, clinical evidence, and supply resilience create commercial advantage

Competitive dynamics in the ICD space are characterized by sustained investment in incremental innovation, strategic partnerships, and selective consolidation. Established manufacturers continue to invest in next-generation lead designs, battery chemistries, and sensing algorithms to extend device longevity and reduce adverse events, while newer entrants and smaller firms are focusing on niche innovations such as wearable defibrillators and software-centric monitoring platforms that integrate with care management systems. Strategic collaborations between device companies and digital health firms are accelerating features like predictive analytics and remote monitoring dashboards, which can shift value conversations from device alone to bundled care solutions.

At the same time, intellectual property portfolios and clinical evidence generation remain pivotal competitive levers; firms that can demonstrate long-term safety and real-world effectiveness through registries and post-market studies gain negotiating power with payers and procurement teams. Supply chain resilience and manufacturing flexibility also differentiate competitors, particularly in a climate where trade policy and component scarcity can affect availability. For commercial teams, the competitive imperative is to align product roadmaps with service offerings and clinical support that address the full lifecycle of device use from implantation through long-term follow-up.

Practical strategic priorities that align clinical evidence generation, product design, and supply chain agility to accelerate adoption and preserve commercial resilience

Industry leaders should adopt an integrated approach that aligns product development, clinical evidence strategies, and supply chain resilience to secure sustainable advantage. Prioritize investments in technologies that demonstrably reduce procedural complications and improve patient experience, while ensuring that clinical trials and registries are designed to capture endpoints that matter to payers and providers. Concurrently, diversify sourcing strategies and consider regional assembly or contract manufacturing to mitigate exposure to tariff and trade policy volatility while maintaining quality and regulatory compliance.

Commercial strategies should emphasize bundled value propositions that combine devices with remote monitoring services and clinician support, enabling clearer demonstrations of outcome improvements and total cost implications for health systems. Strengthen collaboration with centers of excellence and clinician champions to accelerate uptake and to co-create training programs that lower the barrier to adoption in ambulatory settings. Finally, invest in data interoperability and cybersecurity measures to ensure that remote monitoring and device data can be integrated into electronic health records and care pathways securely, thereby increasing clinician trust and patient acceptance.

A transparent, clinician-informed research methodology combining expert interviews and systematic secondary review to ensure robust, actionable insights

The research underpinning this report combined primary qualitative engagement with clinical and commercial experts and secondary synthesis of peer-reviewed literature, regulatory filings, and clinical trial registries to ensure a balanced and evidence-based perspective. Primary engagements included interviews with electrophysiologists, device clinic managers, procurement professionals, and supply chain leaders to capture real-world practice patterns and decision criteria. Secondary sources were systematically reviewed for technology assessments, safety profiles, and comparative analyses to triangulate insights and validate thematic findings.

Analytical rigor was maintained through cross-validation of interview findings against published clinical guidelines and regulatory approvals. Limitations were acknowledged where high-quality long-term data are still emerging, particularly for newer subcutaneous and wearable solutions. The methodology emphasized transparency in source attribution and applied qualitative synthesis to translate heterogeneous data into actionable implications for stakeholders. Quality assurance processes included internal peer review and methodological checks to reduce bias and ensure the relevance of conclusions for commercial and clinical decision-making.

A concise synthesis capturing the strategic balance of innovation, evidence, and operational readiness required to advance ICD therapy responsibly and effectively

The implantable cardioverter defibrillator landscape is at an inflection point characterized by meaningful technological progress, shifting care delivery models, and heightened attention to supply chain and policy risks. Advances in device design and remote capabilities offer clear opportunities to improve patient outcomes and streamline follow-up, yet realizing these benefits requires aligned evidence generation, adaptable commercial strategies, and resilient operations. Health systems and manufacturers that proactively bridge clinical needs with pragmatic service models will be best positioned to deliver value while managing cost and access pressures.

Looking ahead, the successful commercialization of ICD innovations will depend on credible long-term safety data, interoperable digital ecosystems, and partnerships that integrate devices into broader care pathways. By focusing on these priorities, stakeholders can navigate regulatory complexity, address payer expectations, and expand responsible access to life-saving therapy across diverse healthcare environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of wireless remote monitoring and data analytics in ICD implants to enable proactive patient management
  • 5.2. Development of leadless subcutaneous ICD systems reducing infection risk and improving patient comfort
  • 5.3. Implementation of AI-driven arrhythmia detection algorithms in implantable devices to enhance therapy accuracy
  • 5.4. Emergence of MRI-compatible defibrillators enabling broader imaging diagnostics for implanted patients
  • 5.5. Adoption of miniaturized battery technology in ICDs to extend device lifespan and reduce replacement surgeries
  • 5.6. Collaboration between device manufacturers and digital health platforms for seamless patient adherence tracking

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Implantable Cardioverter Defibrillators Market, by Product Type

  • 8.1. Subcutaneous ICDs
  • 8.2. Transvenous ICDs
  • 8.3. Wearable ICDs

9. Implantable Cardioverter Defibrillators Market, by Indication

  • 9.1. Primary Prevention
  • 9.2. Secondary Prevention

10. Implantable Cardioverter Defibrillators Market, by Technology

  • 10.1. MRI Compatible
  • 10.2. Remote Monitoring Enabled

11. Implantable Cardioverter Defibrillators Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Care Centers
  • 11.3. Clinics
  • 11.4. Hospitals

12. Implantable Cardioverter Defibrillators Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Implantable Cardioverter Defibrillators Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Implantable Cardioverter Defibrillators Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Boston Scientific Corporation
    • 15.3.3. Abbott Laboratories
    • 15.3.4. BIOTRONIK SE & Co. KG
    • 15.3.5. MicroPort Scientific Corporation
    • 15.3.6. LivaNova PLC
    • 15.3.7. Lepu Medical Technology Co., Ltd.
    • 15.3.8. Stryker Corporation
    • 15.3.9. ZOLL Medical Corporation
    • 15.3.10. Kestra Medical Technologies Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 83. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 85. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 96. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 106. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 136. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 146. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 147. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 168. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 169. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 178. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 179. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 180. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 181. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 198. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 199. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 208. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 209. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 218. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 219. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 229. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 236. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 237. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 245. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 247. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 252. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 253. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 269. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 271. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 276. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 277. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 285. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE,